ArticleCancer biology & therapy2018

The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib.

Laurence Booth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.